login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

Stereotaxis initiates shipments of the Epoch electrophysiology platform


Friday, 16 Dec 2011 10:32

Stereotaxis has started shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system. 


Initial shipments include system upgrades to the new generation Epoch platform from the Niobe II navigation system for customers in the USA and Europe. The company also announced the installation of the Vdrive Duo mechanical arm robotic navigation system, as part of the Epoch upgrades in Europe. The Vdrive Duo arm allows physicians to remotely manipulate a growing array of devices, such as the loop diagnostic catheter and sheath, while also manipulating the magnetic catheter.


The Epoch platform is designed to improve efficiency and enhance workflow by allowing the physician to control all aspects of the procedure remotely. It combines the proven value of remote magnetic catheter control and the efficiency benefits of remote robotic device manipulation with the Vdrive mechanical arm.


“The Epoch platform has generated tremendous market excitement since its introduction at the annual Heart Rhythm Society meeting in May,” said Michael P Kaminski, president and CEO of Stereotaxis. “As expected, the initial wave of commitments is coming from current customers who see the clear benefit to upgrade their system to Epoch. Additionally, we have experienced a surge in new prospective customers visiting our headquarters to understand how Epoch would fit their EP lab needs. We are excited about the interest in Epoch from current users and the demand curve for prospective customers, and believe we are poised for strong performance in 2012.”




Add New Comment

Related Items


Most popular


Thursday, 26 Feb 2015
Vitaria delivers autonomic regulation therapy for patients who have moderate to severe heart failure with left ventricular dysfunction (ejection fraction < 40%), and who remain symptomatic despite ... Vitaria vagal nerve stimulation system receives CE mark for treatment of chronic heart failure

Bridging during anticoagulation interruption associated with higher bleeding risk in AF patients
Friday, 30 Jan 2015
A subanalysis from the ORBIT-AF registry has found that atrial fibrillation patients who receive bridging anticoagulation therapy during anticoagulation interruption are at higher risk of bleeding ... Bridging during anticoagulation interruption associated with higher bleeding risk in AF patients

Sorin announces enrolment of first patients in the Vanguard clinical study
Thursday, 12 Feb 2015
The Vanguard (Vagal nerve stimulation safeguarding heart failure patients) clinical study evaluates Equilia, a neurostimulation system for heart failure patients. Sorin announces enrolment of first patients in the Vanguard clinical study

Features


SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea
Tuesday, 24 Mar 2015
Martin Cowie (Imperial College London, London, UK) is the principal investigator of the SERVE-HF study, which is assessing the use of adaptive servo-ventilation (PaceWave, ResMed) in chronic heart ... SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea

ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion
Tuesday, 10 Feb 2015
Andreas Goette explains the rationale and details of the ENSURE-AF trial, the largest prospective study evaluating the efficacy and safety of edoxaban (Daiichi Sankyo) compared with enoxaparin/... ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion

Profiles


Hung-Fat Tse
Tuesday, 03 Feb 2015
While Hung-Fat Tse’s initial research interests focused on device therapy for cardiac arrhythmias, ... Hung-Fat Tse

Massimo Santini
Friday, 10 Oct 2014
Massimo Santini performed the first fulguration of the atrioventricular node of resistant ... Massimo Santini

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions